-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) Announces $200M Proposed Public Offering
-
-
-
-
-
-
-
Kymera Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides a Business Update
-
-
-
-
-
-
-
Kymera Therapeutics Appoints Biopharmaceutical Leader Victor Sandor, M.D.C.M., to Board of Directors
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

